The Wall Street Journal (online registration required): Food and Drug Administration documents released Monday suggested the agency was considering reviving a drug that has been highly restricted for nearly three years—the GlaxoSmithKline GSK.LN +0.03% PLC diabetes pill Avandia—and restoring it to full marketing status in the U.S.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now